left Back

Evaluation of a novel paclitaxel-coated intravascular balloon

  • 11 views
  • 30 Aug 2018
Like Comment

Share

Save

Stroke Venous (PVD) Peripheral Vascular Disease (PVD) Aortic Pathology

Biba Medical

Follow

The Charing Cross Symposium (CX) first took place in 1978 at Charing Cross Hospital, Hammersmith, London, and has gone on to become the longest running vascular and endovascular symposium in Europe as well as one of the largest such meetings in the world. London (UK) has been the host city of CX ever since. Until 1998, the symposium was held at Charing Cross Hospital, and between 1999 and 2012 at Imperial College. In 2013, it moved to National Hall, Olympia, and in 2014 to Olympia Grand. The first CX had 100 attendees. In 2018, the Charing Cross Symposium – Controversies Update had more than 4,000 participants, from 86 countries, making it a leading global event. The Charing Cross Symposium raises vascular and endovascular controversies so that a world-class faculty challenges the available evidence in order to reach a consensus after discussion with an expert audience. This forms a three-year cycle. Challenges will be discussed in 2019.

Abraham Tzafriri

A computational scientist at CBSET, Boston, MA, USA. Features in 3 videos on Wondr Medical. Abraham Tzafriri generally speaks on Stroke, Venous (PVD), Peripheral Vascular Disease (PVD), Aortic Pathology, and Renal Denervation (RDN).

Link to profile Follow

Related Videos

open video

Biba Medical

Flexible Tigris stent used with IVUS

open video

Biba Medical

What will be the impact of the new EU medical device regulations on innovation?

open video

Biba Medical

Screening for abdominal aortic aneurysm is cost-effective and a policy on...

open video

EPIC-SEC

Drug Coated Balloons for SFA: Always or in Selective Lesions

open video

Biba Medical

Percutaneous valvuloplasty

open video

EPIC-SEC

Update on Chronic Limb Ischemia: Case Based